Recent approval of swine flu vaccine’s by top pharmaceutical companies GlaxoSmithKline (GSK), Novartis (NVS) and Baxter International (BAX) to help ease influenza pandemic.

Top pharmaceutical companies in conjunction with wealthy nations are to help prevent the spread of the swine flu virus in under developed nations.

With the Swine Flu Virus now a global pandemic and other top biotech companies developing a swine flu vaccine, Vanguard Pharmaceutical’s has been recruited to distribute and promote a natural alternative to these scientific solutions.

Top Biotech Company AVI BioPharma (AVII), which develops RNA-based treatments for diseases like the Ebola virus, muscular dystrophy and the influenza virus has risen in stock price recently.

The UK Department has reported significant drops in the level of swine flu cases in the UK. But with winter coming for the Northern Hemisphere, At risk groups have been reported as the first to receive swine flu vaccine.

Sinovac Biotech is one of the top pharmaceutical companies that has a swine flu vaccine being tested with possible production starting in September. Since the first swine flu symptoms were reported in Mexico in April 2009, Sinovac Biotech stock has jumped over 200% exceeding analyst expectations. How much higher can Sinovac Biotech share price go?

With a micro-injection influenza vaccine currently in phase II of development, Sanofi Adventis has the capability to develop the first swine flu vaccine. To supply the new swine flu virus at a global scale, companies like Sanofi Aventis may join efforts with other top pharmaceutical companies like AVI Biopharma (AVII), Pure Bioscience (PURE), Roche (RHHBY) and Antigenics (AGEN).